The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Active pharmaceutical ingredients (APIs) are the key components in pharmaceutical drugs that produce their intended therapeutic effects, making them essential elements in the development and manufacturing of medicines. However, producing these APIs under full cGMP conditions with speed, efficiency, and quality is a complex undertaking.
From initial research and development to regulatory compliance and scale-up production, biotechnology and pharmaceutical companies face numerous challenges. Thankfully, industry-leading CDMO partners can support these drug developers during pre-clinical, clinical, and commercial phases, ultimately accelerating time to market for small molecules.
At Thermo Fisher Scientific, we were involved in manufacturing 14% of all small molecules approved by the FDA in 2024, and we have over 50 years of experience in API development and manufacturing. To provide a comprehensive overview of our API capabilities, we’ve developed a brochure that outlines our end-to-end development and manufacturing services.
Specifically, the brochure’s contents include:
- Broad overview of our API offerings
- Map of our global network of facilities
- Drug substance development capabilities
- Drug substance manufacturing capabilities
- Commitment to sustainability and clean chemistry
Download the brochure to learn more.